SEC Filing Summary: Bellevue Life Sciences Acquisition Corp.
Business Context and Reporting Period
This Form 8-K was filed by Bellevue Life Sciences Acquisition Corp. (BLAC) on September 20, 2024. The registrant is a Delaware corporation and an emerging growth company operating as a Special Purpose Acquisition Company (SPAC). The filing reports on amendments to existing promissory notes entered into on the same date.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. The only specific financial figures disclosed relate to the principal amounts of two amended promissory notes:
- Whang Promissory Note: Principal amount of $75,000.
- Pan Promissory Note: Principal amount of $60,000.
No data regarding total debt, liquidity, or other balance sheet metrics is provided in this document.
Material Changes
The material change reported is the extension of the maturity dates for two unsecured promissory notes previously issued to related parties:
- Whang Note: Originally issued February 9, 2024, to Jun Chul Whang (Board Member). Maturity extended to the earlier of March 31, 2025, or the consummation of an initial business combination.
- Pan Note: Originally issued March 8, 2024, to Josh Pan (Member of the Sponsor's management). Maturity extended to the earlier of March 31, 2025, or the consummation of an initial business combination.
No other terms of the notes were amended.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or specific risk factors beyond the standard disclosure that the notes are contingent on the consummation of a business combination. The extension of these notes indicates the company is continuing to seek a target for its initial business combination.
Investor Verification Checklist
- Verify the full text of the Whang and Pan Promissory Note Amendments (Exhibits 10.1 and 10.2) to confirm no hidden terms were altered.
- Confirm the current status of the company's search for an initial business combination target.
- Review the company's most recent 10-Q or 10-K for updated cash balances and total debt obligations, as this 8-K does not provide a full financial picture.
- Check for any subsequent filings regarding the redemption of shares or liquidation if a business combination is not completed by the new maturity dates.